June 25, 2015 / 5:03 PM / 2 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Methode Electronics, Teekay Tankers, Penn Virginia

6 Min Read

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Healthcare stocks jumped after the U.S. Supreme Court upheld tax subsidies key to Obamacare while a jump in consumer spending sent the broader U.S. market higher. The Dow Jones industrial average was unchanged at 17,966.6, the S&P 500 was up 0.08 percent at 2,110.32 and the Nasdaq Composite was up 0.10 percent at 5,127.58.

** CLEVELAND BIOLABS INC, $6.44, +127.56 pct

The drug developer signed a private placement agreement with David Davidovich, a venture capital investor, for sale of 6.4 million common shares at $3.87/share for $25 million.

** UNITEDHEALTH GROUP, $122.28, +2.61 pct

** CENTENE CORP, $80.72, +3.06 pct

** HCA HOLDINGS, $90.6, +8.67 pct

** TENET HEALTHCARE CORP, $57.17, +14.16 pct

U.S. hospital shares surged, with several hitting all-time highs, and other healthcare names rallied on Thursday after the U.S. Supreme Court upheld tax subsidies key to President Barack Obama's signature healthcare law.

BREAKINGVIEWS-Supreme Court tells Obamacare opponents to move on

** IAC/INTERACTIVECORP, $81.27, +5.19 pct

The media company, controlled by media mogul Barry Diller, said it planned to list its dating business, which includes dating website Match.com and mobile dating app Tinder.

BREAKINGVIEWS-IAC investors may get a Match from partial divorce

** METHODE ELECTRONICS INC, $30.27, -29.72 pct

The electronic component maker reported lower-than-expected Q4 profit and revenue as sales from interface business remained flat due to lower demand in Europe and Asia.

** VENAXIS INC, $0.4711, -15.27 pct

The diagnostic test maker said FDA reviewers needed more clinical data supporting revised intended use for blood testing system, APPY1. On Jan. 29, the agency did not find APPY1 to be "substantially equivalent" to standard of care.

** REAL GOODS SOLAR INC, $4.6299, +27.20 pct

The solar company converted subordinated debt to class A shares and will convert outstanding principal of $3.15 mln and accrued interest of $1.09 million to 1.28 million Class A stock at Tuesday's closing price of $3.29.

** WORLD ACCEPTANCE CORP, $66.14, -20.14 pct

Brokerage FBR Capital Markets downgraded the lender's stock to "market perform" from "outperform.

** BROADWIND ENERGY INC, $4.32, +8.82 pct

The energy infrastructure provider said that it got $50 million in new tower orders from a U.S. wind turbine maker.

** PENN VIRGINIA CORP, $4.93, +10.79 pct

The U.S. oil and gas producer's shares rose as much as 15.5 percent following a report that BP Plc had offered to buy the company for $8 per share.

** CREE INC, $27.3101, -10.63 pct

The company, which makes lighting and semiconductor products, said it would reduce manufacturing capacity at its light-emitting diode factory, as it struggles with a decline in prices, and take an $85 million restructuring charge.

** MAGNUM HUNTER RESOURCES CORP, $1.85, +5.71 pct

The oil and natural gas producer said it expected to raise $600-$700 million by selling its 45.53 percent stake in its natural gas gathering subsidiary, Eureka Hunter Holdings.

** NETFLIX INC, $658.48, -2.97 pct

Brokerage Citigroup cut its rating on the online video streaming service to "neutral" from "buy", according to theflyonthewall.com. Citigroup analyst Mark May believes that "more signs of traction in recently launched international markets are needed before shares can reach his upside case of over $950," according to theflyonthewall.com.

** AQUINOX PHARMACEUTICALS INC, $7.47, -5.20 pct

The pain drug developer said its drug for bladder pain did not have statistically significant effect on patients in mid-stage study, compared with placebo.

** ELI LILLY AND CO, $86.03, +4.58 pct

The drugmaker said it won patent case in Court of Appeal in London over its blockbuster lung cancer drug Alimta, dealing a blow to generic challenger Actavis, which has since changed its name to Allergan Plc.

** TRANSUNION, $24.62, +9.42 pct

Shares of the credit bureau rose as much as 10 percent in their debut, valuing the company at about $4.4 billion.

** TEEKAY TANKERS LTD, $6.9, -6.76 pct

Brokerage UBS analysts downgraded the shipping company's stock to "sell" from "neutral" in a note titled "A good company does not always mean a good stock".

** NEWPARK RESOURCES INC, $8.51, +7.99 pct

Brokerage Raymond James analysts upgraded the oilfield services provider stock to 'strong buy' from 'outperform' but cut price target to $11 from $13.

"We do not think the market is properly valuing the company's strong financial position and growth potential in 2016 and beyond," analysts wrote.

** MERRIMACK PHARMACEUTICALS INC, $12.705, +6.76 pct

The cancer drug developer says FDA grants priority review status to experimental cancer drug MM-398 and sets decision date for Oct. 24.

** WINNEBAGO INDUSTRIES INC, $22.17, +7.10 pct

The largest U.S. motorhome maker reported better-than-expected quarterly revenue as it shipped more vehicles. (Compiled by Anya George Tharakan in Bengaluru; Editing by Sriraj Kalluvila)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below